Skip to main content
. 2023 Sep 20;9:120–124. doi: 10.1016/j.ijregi.2023.08.002

Table 2.

Treatment received for the illness (n = 1459).

Treatment Yes
No
N % N %
Oxygen therapy 1,420 97.3 39 2.7
Symptomatic treatmenta 1,240 85.5 219 15.0
Steroids (Dexamethasone) 1,186 81.3 273 18.7
Vitamin C 809 55.4 650 44.6
Non- invasive ventilationb 732 50.2 727 49.8
Zinc 699 47.9 760 52.1
Heparin 664 45.5 795 54.5
Azithromycin 610 41.8 849 58.2
Invasive ventilationc 588 40.3 871 59.7
Antiviral (Remdesivir) 543 37.2 916 62.8
Vitamin D 470 32.2 989 67.8
Ivermectin 241 16.5 1,218 83.5
Hydroxychloroquine 169 11.6 1,290 88.4
Convalescent plasma therapy 152 10.4 1,307 89.6
Warfarin 144 9.9 1,315 90.1
a

Paracetamol, Oral rehydration solution, Ringer's lactate

b

Non-invasive ventilation include CPAP, Bi-PAP

c

Invasive ventilated patients included mechanical ventilator